AI Science Tracker
EN

Development of a predictive model for the risk of microalbuminuria: comparison of 2 machine learning algorithms.

Not stated in the abstract reviewed · 31 May 2024 · medicine

Discovery

Development of a predictive model for the risk of microalbuminuria: comparison of 2 machine learning algorithms.

Source check: Source checked. Not independent scientific confirmation.

Finding: A Random Forest model using nine clinical variables predicted MAU among 981 hospitalized T2DM patients (test AUC 0.87); SHAP associated HbA1c, NLR and 25(OH)D with risk. This is a single-center retrospective prediction, not evidence of clinical benefit.

Technology: logistic screening selects nine variables, then Random Forest and BP neural-network models predict MAU; SHAP interprets RF feature contributions.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
logistic screening selects nine variables, then Random Forest and BP neural-network models predict MAU; SHAP interprets RF feature contributions.
Test and result
retrospective data from 981 hospitalized T2DM patients (333 MAU) produced an RF risk model with reported test AUC 0.87 and associations for HbA1c, NLR and 25(OH)D.
Limitation / still unknown
Methods: random 70/30 training/test split, SMOTE applied to training data, and five-fold cross-validation. Validation is internal and single-center; it does not establish clinical benefit or external performance.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s40200-024-01440-4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.